Nathan Caffo
CEO & President
Genetics
Presage Biosciences
United States of America
Biography
Nathan Caffo is a life sciences professional whose 23-year industry career has been focused on personalized medicine and applications of genomic technology. Before joining Presage as its first employee in 2009, he consulted for a UK-based diagnostic company, Curidium Medica, and led the efforts to identify an acquirer for that business. Mr. Caffo also led drug in-licensing at Perlegen Sciences, a genomic medicine spin-off of Affymetrix. Prior to that, he worked at Applied Biosystems (now Life Technologies) and its sister company Celera (now Quest Diagnostics) for 11 years in a number of technical and business roles, including managing the company’s genomics service business. Mr. Caffo has a B.S. in Microbiology from Pennsylvania State University.
Research Interest
Genetics
